Do you find our website to be helpful?
Yes   No

Assessing the Embolization of Neurovascular Lesions Using the Penumbra Smart Coil (SMART)

Penumbra Image

This is a prospective, multi-center study of patients treated in accordance with the cleared indications for the Penumbra SMART CoilTM System (SMART), Penumbra Coil 400TM (PC 400), and Penumbra Occlusion DeviceTM (POD). Data for each patient are collected in accordance with the standard of care at each participating hospital through one-year follow-up. Approximately 1,000 patients with intracranial aneurysms or other malformations treated by the SMART CoilTM System at up to 100 centers will be enrolled. The primary objective of this registry is to gather post market data on the Penumbra SMART CoilTM System in the treatment of intracranial aneurysms and other malformation.

If you would like to explore more clinical information about this trial, please see the trial page on ClinicalTrials.gov

Author
Richard Bellon, MD Dr. Richard Bellon is a Neurointerventional Surgeon in Denver, CO

You Might Also Enjoy...

COMPASS Trial: A Direct Aspiration First Pass Technique

Intravenous (IV) tissue plasminogen activator (tPA) administration has been shown to be safe and effective for treatment of Acute Ischemic Stroke (AIS) within 3 hours of symptom onset, and newer evidence has shown potential benefit out to 4.5 hours.

We Are Committed to Clinical Research

RIA has a rich history of participation in clinical research and innovation dating back to the 1980s.  Many of our physicians believe it is important to contribute to science and advance medicine.